Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | JAK1 |
Variant | S646P |
Impact List | missense |
Protein Effect | gain of function |
Gene Variant Descriptions | JAK1 S646P lies within the protein kinase domain 1 of the Jak1 protein (UniProt.org). S646P results in autophosphorylation of Jak1, constitutive activation of Stat3 and Erk, and is transforming in culture (PMID: 28410228). |
Associated Drug Resistance | |
Category Variants Paths |
JAK1 mutant JAK1 act mut JAK1 S646P |
Transcript | NM_002227.4 |
gDNA | chr1:g.64846700A>G |
cDNA | c.1936T>C |
Protein | p.S646P |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_001321853 | chr1:g.64846700A>G | c.1936T>C | p.S646P | RefSeq | GRCh38/hg38 |
XM_047419674.1 | chr1:g.64846700A>G | c.1936T>C | p.S646P | RefSeq | GRCh38/hg38 |
NM_001321856.1 | chr1:g.64846700A>G | c.1936T>C | p.S646P | RefSeq | GRCh38/hg38 |
NM_001320923 | chr1:g.64846700A>G | c.1936T>C | p.S646P | RefSeq | GRCh38/hg38 |
NM_002227.4 | chr1:g.64846700A>G | c.1936T>C | p.S646P | RefSeq | GRCh38/hg38 |
NM_001321852 | chr1:g.64846700A>G | c.1936T>C | p.S646P | RefSeq | GRCh38/hg38 |
NM_001321854 | chr1:g.64846700A>G | c.1936T>C | p.S646P | RefSeq | GRCh38/hg38 |
NM_001321854.2 | chr1:g.64846700A>G | c.1936T>C | p.S646P | RefSeq | GRCh38/hg38 |
NM_001321856.2 | chr1:g.64846700A>G | c.1936T>C | p.S646P | RefSeq | GRCh38/hg38 |
NM_001321855.1 | chr1:g.64846700A>G | c.1936T>C | p.S646P | RefSeq | GRCh38/hg38 |
NM_002227 | chr1:g.64846700A>G | c.1936T>C | p.S646P | RefSeq | GRCh38/hg38 |
NM_001321853.2 | chr1:g.64846700A>G | c.1936T>C | p.S646P | RefSeq | GRCh38/hg38 |
NM_001321854.1 | chr1:g.64846700A>G | c.1936T>C | p.S646P | RefSeq | GRCh38/hg38 |
NM_001321855 | chr1:g.64846700A>G | c.1936T>C | p.S646P | RefSeq | GRCh38/hg38 |
NM_001321852.1 | chr1:g.64846700A>G | c.1936T>C | p.S646P | RefSeq | GRCh38/hg38 |
NM_001321853.1 | chr1:g.64846700A>G | c.1936T>C | p.S646P | RefSeq | GRCh38/hg38 |
NM_002227.3 | chr1:g.64846700A>G | c.1936T>C | p.S646P | RefSeq | GRCh38/hg38 |
NM_001321852.2 | chr1:g.64846700A>G | c.1936T>C | p.S646P | RefSeq | GRCh38/hg38 |
NM_001320923.2 | chr1:g.64846700A>G | c.1936T>C | p.S646P | RefSeq | GRCh38/hg38 |
NM_001321855.2 | chr1:g.64846700A>G | c.1936T>C | p.S646P | RefSeq | GRCh38/hg38 |
XM_047419675.1 | chr1:g.64846700A>G | c.1936T>C | p.S646P | RefSeq | GRCh38/hg38 |
NM_001321856 | chr1:g.64846700A>G | c.1936T>C | p.S646P | RefSeq | GRCh38/hg38 |
NM_001320923.1 | chr1:g.64846700A>G | c.1936T>C | p.S646P | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
JAK1 S646P | Advanced Solid Tumor | sensitive | Ruxolitinib | Preclinical - Cell culture | Actionable | In a preclinical study, treatment with Jakafi (ruxolitinib) resulted in inhibition of both Jak1 autophosphorylation and Stat3 and Erk activity, and inhibition of cell proliferation in culture in transformed cells expressing JAK1 S646P (PMID: 28410228). | 28410228 |